The "Selective Vulnerability through Metabolic Licensing" Model

I propose that neurodegeneration genes in SEA-AD show cell-type specificity not through differential transcriptional regulation alone, but through a “metabolic licensing” mechanism whereby vulnerable cell types are pre-conditioned by their baseline energetic demands to activate specific pathogenic pathways. Specifically, I hypothesize that excitatory neurons and certain astrocytic subpopulations in vulnerable brain regions (entorhinal cortex, CA1) constitutively operate at 70-80% of their ATP production capacity, creating a “metabolic brittleness” that selectively sensitizes them to amyloid-β and tau oligomer-induced mitochondrial stress. This would explain why neuroinflammatory genes (IL1β, TNF) show sparse activation across microglia in many SEA-AD cases, yet excitatory neurons simultaneously upregulate NLRP3 inflammasome components—not because microglia are inactive, but because only metabolically strained neurons can trigger this response. Testable prediction: Single-cell RNA-seq combined with SCENITH (metabolic profiling) should reveal that neurons expressing high levels of neurodegeneration-associated genes have baseline mitochondrial reserve capacity <25%, whereas resilient neuronal populations maintain >50%. Furthermore, selective optogenetic hyperstimulation of low-reserve neurons should trigger rapid expression of tau phosphorylation and amyloid processing genes within 6-12 hours, independent of amyloid exposure.

Debate provenance: derived from debate debate-seaad-20260402 on question: Cell-type specific expression patterns of neurodegeneration genes in SEA-AD. Consensus signal: domain_expert, skeptic, theorist discussed the mechanism terms ATP, CA1, Licensing, Metabolic, Model, NLRP3, RNA, SCENITH. Novelty signal: skeptic-discussed-counterarguments.